Digoxin level and clinical manifestations as determinants in the diagnosis of digoxin toxicity

Therapeutic Drug Monitoring

Volumn 22, Issue 2, 2000, Pages 163-168

  Abad Santos, Francisco ^a   Carcas, Antonio J ^b   Ibáñez, Carmen ^b   Frías, Jesús ^b  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b NONE

Author keywords

Digoxin level; Digoxin toxicity; Inpatients; Therapeutic drug monitoring

Indexed keywords

DIGITALIS; DIGOXIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC VALUE; DIGITALIS INTOXICATION; DIGOXIN BLOOD LEVEL; DRUG DETERMINATION; FEMALE; HEART AUTOMATICITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; TOXICITY TESTING;

ADULT; AGED; AGED, 80 AND OVER; DIGOXIN; DRUG MONITORING; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS;

EID: 0034127539     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-200004000-00004     Document Type: Article

References (27)

1. Beller GA. Smith TW, Abelmann WH, Haber E. Hood WB. Digitalis intoxication: a prospective clinical study with serum level correlations. N Engl J Med 1971;284:989-97.
2. Evered DC, Chapman C. Plasma digoxin concentrations and digoxin toxicity in hospital patients. Br Heart J 1971;33:540-5.
3. Mahdyoon H, Battilana G, Rosman H, Goldstein S, Gheorghiade M. The evolving pattern of digoxin intoxication: observations at a large urban hospital from 1980 to 1988. Am Heart J 1990;120: 1189-94.
4. Allen NM, Dunham GD. Treatment of digitalis intoxication with emphasis on the clinical use of digoxin immune Fab. DICP Ann Pharmacother 1990;24:991-8.
5. Kernan WN, Castellsague J, Perlman GD, Ostfeld A. Incidence of hospitalization for digitalis toxicity among elderly patients. Am J Med 1994;96:426-31.
6. Mordel A, Halkin H, Zulty L, Almog S, Ezra D. Quinidine enhances digitalis toxicity at therapeutic serum digoxin levels. Clin Pharmacol Ther 1993;53:457-62.
7. Pahor M, Guralnik JM, Gambassi G, Bernabei R, Carosella L, Carbonin P. The impact of age on risk of adverse drug reactions to digoxin. J Clin Epidemiol 1993;46:1305-14.
8. Williamson KM, Thrasher KA, Fulton KB, et al. Digoxin toxicity: an evaluation in current clinical practice. Arch Intern Med 1998; 158:2444-9.
9. Einarson TR. Drug-related hospital admissions. Ann Pharmacother 1993;27:832-40.
10. de Abajo FJ, Frías J, Lopo CR, et al. Las reacciones adversas a medicamentos como un motivo de consulta al servicio de urgencias de un hospital general. Med Clin (Barc) 1989;92:530-5.
11. Ganjo B, de Abajo FJ, Castro MAS, Lopo CR, Carcas A, Frías J. Hospitalizaciones motivadas por fármacos: un estudio prospectivo. Rev Clin Esp 1991;188:7-12.
12. Reuning RH, Geraets DR. Digoxin. In: Evans WE, Schentag JJ, Jusko WJ, eds. Applied Pharmacokinetics, principles of therapeutical drug monitoring. 1st Edition. Spokane: Applied Therapeutics: 1986;570-623.
13. Krisanda TJ. Digitalis toxicity: using immunotherapy when supportive care is not enough. Postgrad Med 1992;91:273-84.
14. Smith TW, Haber E. Digoxin intoxication: the relationship of clinical presentation to serum digoxin concentration. J Clin Invest 1970;49:2377-86.
15. Aronson JK, Grahame-Smith DG, Wigley FM. Monitoring digoxin therapy. The use of plasma digoxin concentration measurements in the diagnosis of digoxin toxicity. Quart J Med 1978;186:111-22.
16. Sonnenblick M, Abraham AS, Meshulam Z, Eylath U. Correlation between manifestations of digoxin toxicity and serum digoxin, calcium, potassium and magnesium concentrations and arterial pH. Br Med J 1983;286:1089-91.
17. de Abajo FJ, Frías J. Estimación de la probabilidad de toxicidad digitálica mediante la combinación de criterios clínicos con la digoxinemia. Med Clin (Barc) 1991;97:77-8.
18. Ordog GJ, Benaron S, Bhasin V, Wassenberg J. Serum digoxin levels and mortality in 5,100 patients. Ann Emerg Med 1987;16: 32-9.
19. Young IS, Goh EML, McKillop UH, Standford CF, Nicholls DP, Trimble ER. Magnesium status and digoxin toxicity. Br J Clin Pharmacol 1991;32:717-21.
20. Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
21. Boman K. Digitalis intoxication in geriatric in-patients: a prospective clinical study of the value of serum digitalis concentration. Acta Med Scand 1983;214:345-51.
22. Park GD, Spector R, Goldberg MJ, Feldman RD. Digoxin toxicity in patients with high serum digoxin concentration. Am J Med Sci 1987;294:423-8.
23. Piergies AA, Worwag EM, Atkinson AJ. A concurrent audit of high digoxin plasma levels. Clin Pharmacol Ther 1994;55:353-8.
24. Fogelman AM, La Mont JT, Finkelstein S, Rado E, Pearce ML. Fallibility of plasma-digoxin in differentiating toxic from nontoxic patients. Lancet 1971;2:727-9.
25. Jelliffe RW. Effect of serum potassium upon risk of digitalis toxicity. Ann Intern Med 1973;78:821.
26. Shapiro W. Correlative studies of serum digitalis levels and the arrhythmias of digitalis intoxication. Am J Cardiol 1978;41:852-9.
27. Wofford JL, Hickey AR, Ettinger WH, Furberg CD. Lack of age-related differences in the clinical presentation of digoxin toxicity. Arch Intern Med 1992;152:2261-4.